|
| 產(chǎn)地 | 進(jìn)口、國產(chǎn) |
| 品牌 | 上海莼試 |
| 保存條件 | Store at -20 °C |
| 貨號(hào) | CS10805 |
| 應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
| CAS編號(hào) | |
| 抗體名 | Anti-phospho-PKC delta (Ser645) |
| 克隆性 | |
| 靶點(diǎn) | 詳見說明書 |
| 適應(yīng)物種 | 詳見說明書 |
| 形態(tài) | 詳見說明書 |
| 宿主 | 詳見說明書 |
| 亞型 | IgG |
| 標(biāo)識(shí)物 | 詳見說明書 |
| 濃度 | 1mg/1ml% |
| 免疫原 | KLH conjugated Synthesised phosphopeptide derived from human PKC delta around the phosphorylation site of Ser645 |
全、新、優(yōu)、品、好四大特點(diǎn)：
磷酸化蛋白激酶C亞性D型抗體費(fèi)用 全：公司提供上萬種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標(biāo)準(zhǔn)品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細(xì)胞等，基本上各種科研所需產(chǎn)品在我司都能找到。
新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。
好：我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊(duì)，產(chǎn)品一旦售出，實(shí)驗(yàn)過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時(shí)沒有任何的后顧之憂。
磷酸化蛋白激酶C亞性D型抗體費(fèi)用 英文名稱 Anti-phospho-PKC delta (Ser645)
中文名稱 磷酸化蛋白激酶C亞性D型抗體費(fèi)用
別 名 PRKCD(phospho S645); PKCδ(Phospho-Ser645); MAY 1; MAY1; nPKC delta; PCKd; PKC d; PKC delta; PKC-d; PKCD; PKCdelta; PRKC D; PRKC delta; PRKC-d; PRKCd; Protein Kinase C delta; Protein kinase C delta type; Protein Kinase Cdelta; KPCD_HUMAN.
產(chǎn)品屬性：
濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg
抗體來源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human
產(chǎn)品類型 一抗 磷酸化抗體
研究領(lǐng)域 細(xì)胞生物 免疫學(xué) 信號(hào)轉(zhuǎn)導(dǎo) 轉(zhuǎn)錄調(diào)節(jié)因子 激酶和磷酸酶
蛋白分子量 predicted molecular weight: 77kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated Synthesised phosphopeptide derived from human PKC delta around the phosphorylation site of Ser645
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
磷酸化蛋白激酶C亞性D型抗體費(fèi)用 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 Protein Kinase C delta (PKC delta) is a 78 kDa member of the novel group (nPKCs: sensitive to diacylglycerol, phosphatidylserine, and phorbol esters) of the PKC family of serine/threonine kinases that are involved in a wide range of physiological processes including mitogenesis, cell survival and transcriptional regulation. PKC delta is an ubiquitously expressed PKC isozyme that has been implicated in the regulation of multiple cellular processes including cell cycle progression and apoptosis.
Function : Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that plays contrasting roles in cell death and cell survival by functioning as a pro-apoptotic protein during DNA damage-induced apoptosis, but acting as an anti-apoptotic protein during cytokine receptor-initiated cell death, is involved in tumor suppression as well as survival of several cancers, is required for oxygen radical production by NADPH oxidase and acts as positive or negative regulator in platelet functional responses. Upon DNA damage, activates the promoter of the death-promoting transcription factor BCLAF1/Btf to trigger BCLAF1-mediated p53/TP53 gene transcription and apoptosis. In response to oxidative stress, interact with and activate CHUK/IKKA in the nucleus, causing the phosphorylation of p53/TP53. In the case of ER stress or DNA damage-induced apoptosis, can form a complex with the tyrosine-protein kinase ABL1 which trigger apoptosis independently of p53/TP53. In cytosol can trigger apoptosis by activating MAPK11 or MAPK14, inhibiting AKT1 and decreasing the level of X-linked inhibitor of apoptosis protein (XIAP), whereas in nucleus induces apoptosis via the activation of MAPK8 or MAPK9. Upon ionizing radiation treatment, is required for the activation of the apoptosis regulators BAX and BAK, which trigger the mitochondrial cell death pathway. Can phosphorylate MCL1 and target it for degradation which is sufficient to trigger for BAX activation and apoptosis. Is required for the control of cell cycle progression both at G1/S and G2/M phases. Mediates phorbol 12-myristate 13-acetate (PMA)-induced inhibition of cell cycle progression at G1/S phase by up-regulating the CDK inhibitor CDKN1A/p21 and inhibiting the cyclin CCNA2 promoter activity. In response to UV irradiation can phosphorylate CDK1, which is important for the G2/M DNA damage checkpoint activation. Can protect glioma cells from the apoptosis induced by TNFSF10/TRAIL, probably by inducing increased phosphorylation and subsequent activation of AKT1. Is highly expressed in a number of cancer cells and promotes cell survival and resistance against chemotherapeutic drugs by inducing cyclin D1 (CCND1) and hyperphosphorylation of RB1, and via several pro-survival pathways, including NF-kappa-B, AKT1 and MAPK1/3 (ERK1/2). Can also act as tumor suppressor upon mitogenic stimulation with PMA or TPA. In N-formyl-methionyl-leucyl-phenylalanine (fMLP)-treated cells, is required for NCF1 (p47-phox) phosphorylation and activation of NADPH oxidase activity, and regulates TNF-elicited superoxide anion production in neutrophils, by direct phosphorylation and activation of NCF1 or indirectly through MAPK1/3 (ERK1/2) signaling pathways. May also play a role in the regulation of NADPH oxidase activity in eosinophil after stimulation with IL5, leukotriene B4 or PMA. In collagen-induced platelet aggregation, acts a negative regulator of filopodia formation and actin polymerization by interacting with and negatively regulating VASP phosphorylation. Downstream of PAR1, PAR4 and CD36/GP4 receptors, regulates differentially platelet dense granule secretion; acts as a positive regulator in PAR-mediated granule secretion, whereas it negatively regulates CD36/GP4-mediated granule release. Phosphorylates MUC1 in the C-terminal and regulates the interaction between MUC1 and beta-catenin.
Subunit : Interacts with PDK1 (via N-terminus region), RAD9A, CDCP1, MUC1 and VASP.
Subcellular Location : Cytoplasm. Cytoplasm, perinuclear region. Nucleus. Endoplasmic reticulum. Mitochondrion. Cell membrane; Peripheral membrane protein.
Similarity : Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. PKC subfamily.
Contains 1 AGC-kinase C-terminal domain.
Contains 1 C2 domain.
Contains 2 phorbol-ester/DAG-type zinc fingers.
Contains 1 protein kinase domain.
Database links : UniProtKB/Swiss-Prot: Q05655.2
實(shí)驗(yàn)流程：
正在熱銷的相關(guān)產(chǎn)品：
Anti-AKAP12/FITC 熒光素標(biāo)記絲氨酸抑制蛋白激酶C底物抗體IgGMulti-class antibodies規(guī)格： 0.2ml
GFAP(Glial Fibrillary Acidic Protein) 膠質(zhì)纖維酸性蛋白(抗原)Multi-class antibodies規(guī)格： 0.5mg
酸脫氫酶激酶4抗體 Anti-Pdk4 0.1ml
Sox3 英文名稱： 轉(zhuǎn)錄因子Sox3抗體 0.2ml
ERK1 + ERK2 英文名稱： 原活化蛋白激酶1/2抗體 0.1ml
Rhesus antibody Rh phospho-NDEL1(Ser231) 磷酸化中心粒蛋白Nudel抗體 規(guī)格 0.1ml
GFAP(Glial Fibrillary Acidic Protein) 膠質(zhì)纖維酸性蛋白(抗原)Multi-class antibodies規(guī)格： 0.5mg
Anti-HA tag/FITC 熒光素標(biāo)記HA tag標(biāo)簽抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Anti-PCNA/FITC 熒光素標(biāo)記增殖細(xì)胞核抗原抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh Bax Bax抗體 規(guī)格 0.1ml
ADAMTS7 peptide/HRP 辣根過氧化物酶標(biāo)記整合素樣金屬蛋白酶與凝血酶1型-7抗原 1mg
GABR B3 英文名稱： G基受體3抗體 0.2ml
Rhesus antibody Rh Rabbit anti-Rat IgM whole serum 兔抗大鼠IgM抗血清 規(guī)格 1ml
Anti-PCNA/FITC 熒光素標(biāo)記增殖細(xì)胞核抗原抗體IgGMulti-class antibodies規(guī)格： 0.2ml
TNF- Alpha 小鼠壞死因子-αMulti-class antibodies規(guī)格： 48T
Anti-ET-1 內(nèi)皮素-1抗體Multi-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh MSF/Cell division control protein septin D1 細(xì)胞周期調(diào)控蛋白D1抗體 規(guī)格 0.2ml
aZP(Human anti-zona pellucida antibody,aZP) ELISA Kit 人抗透明帶抗體 96T
Signal recognition particle 英文名稱： 信號(hào)識(shí)別顆?？贵w 0.1ml
C19orf73 英文名稱： 19號(hào)染色體開放閱讀框73抗體 0.1ml
Anti-ET-1 內(nèi)皮素-1抗體Multi-class antibodies規(guī)格： 0.2ml
SolubleStarchMedium
Demi-Fraser肉湯基礎(chǔ) 與Fraser肉湯添加劑合用，選擇性增強(qiáng)食品樣本中李斯特菌 500g incubation media Demi-Fraser肉湯基礎(chǔ) 與Fraser肉湯添加劑合用，選擇性增強(qiáng)食品樣本中李斯特菌 500g
貝形側(cè)耳、鷹翅菌 食用 支/瓶
mEC+nBroth
FungiMedium
ColumbiaAgarMedium
錳鹽營(yíng)養(yǎng)瓊脂 250(g) incubation media 錳鹽營(yíng)養(yǎng)瓊脂 250(g)
志賀氏菌顯色培養(yǎng)基 1000ml/瓶 志賀氏菌顯色培養(yǎng)基
游離生物素測(cè)定培養(yǎng)基250用于*食品和乳粉中游離生物素測(cè)定incubationmedia游離生物素測(cè)定培養(yǎng)基250用于*食品和乳粉中游離生物素測(cè)定
動(dòng)力-鹽培養(yǎng)基 250g 用于產(chǎn)氣莢膜梭菌的動(dòng)力試驗(yàn)
磷酸化蛋白激酶C亞性D型抗體費(fèi)用 改良馬丁培養(yǎng)基(真菌培養(yǎng)基) 規(guī)格： 250g 用途： 用于真菌培養(yǎng)及藥品和生物制品無菌檢查用。(CP)
酪蛋白消化物-大豆卵磷脂-吐溫20培養(yǎng)基(SCDLP 20 肉湯) 規(guī)格： 250g 用途： 用于粘稠或膠狀樣品的細(xì)菌培養(yǎng)，還用于藥品檢測(cè)的稀釋液和化妝品中需氧嗜溫性細(xì)菌的檢測(cè)。(GB、U...
孟加拉紅培養(yǎng)基(虎紅瓊脂) 規(guī)格： 250g 用途： 供霉菌和酵母菌的計(jì)數(shù)、分離、培養(yǎng)用。(GB)
Baird-Parker瓊脂基礎(chǔ) 規(guī)格： 250g 用途： 用于凝固酶陽性葡萄球菌的選擇性分離培養(yǎng)和計(jì)數(shù)，滅菌冷卻至50℃加入卵黃亞碲酸增菌液。(GB、S...
技術(shù)外包服務(wù):
★磷酸化蛋白激酶C亞性D型抗體費(fèi)用 分子生物學(xué)：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué)：基因合成、引物合成、基因測(cè)序、載體構(gòu)建等
★蛋白工程：原核、哺乳動(dòng)物蛋白表達(dá)系統(tǒng)等
★病毒包裝：腺病毒、慢病毒等
★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★細(xì)胞工程：細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。
|
|
|
|
|
